| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a17209ccc336ebb9b67deef73d6609da |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-20 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-12 |
| filingDate |
2004-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2006-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a2ce9988b3e5a39d44a3f21839438f3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04d2b13f39db4b5352ccf90f305b2d1f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d1886771fc0a0226af3816a1ceab97dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4be9f010aa5c12e9d3cd42917d531031 |
| publicationDate |
2006-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-7119211-B2 |
| titleOfInvention |
Process for preparing optically active 3-(methylamino)-1-(2-thienyl) propan-1-ol and intermediates for preparation |
| abstract |
Disclosed is a process for commercial preparation of 3-(methylamino)-1-(2-thienyl)propan-1-ol (hereinafter abbreviated as “MMAA”) of the formula below: n nThe process is carried out by the diastereomeric salt formation method using optically active mandelic acid or its derivatives, or an optically active tartaric acid derivative as the resolving agent. The product compound, diastereomeric satls, is useful as the intermediate for producing pharmaceuticals, such as duloxetine. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007191471-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011128370-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11103499-B2 |
| priorityDate |
2004-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |